Market Wire - AGI Therapeutics plc announces key findings of clinical PK study of arbaclofen (AGI-006)
Friday, November 7th, 2008AGI announces key findings of clinical PK study of arbaclofen (AGI-006)
Dublin, Ireland, 2 April 2008 - AGI Therapeutics plc (”AGI” or the “Company”)
(AIM, IEX: AGI), a speciality pharmaceutical company focused on gastrointestinal
drug products, today announces the key…
